TRIAMSINOLON PREPARATI YORDAMIDA YUZ VA BOʻYIN SOHASIDA JOYLASHGAN YANGI VA ESKI KELOID CHANDIQLARNI DAVOLASH SAMARADORLIGINI TAQQOSLASH

Authors

DOI:

https://doi.org/10.5281/zenodo.22807729

Keywords:

keloid chandiq, triamsinolon atsetonid, kortikosteroid inyeksiyasi, chandiqlarni davolash, yuz-boʻyin jarrohligi

Abstract

Ushbu tadqiqot yuz va boʻyin sohasidagi keloid chandiqlarni davolashda triamsinolon atsetonid preparatining yangi (6 oygacha) va eski (6 oydan 10 yilgacha) chandiqlardagi samaradorligini taqqoslashga yoʻnaltirilgan. Tadqiqotga 18–55 yosh oraligʻidagi jami 56 nafar bemor jalb etildi. Har 4 haftada bir marta 40 mg/ml dozada intralezional inyeksiya 3 kurs davomida amalga oshirildi. Natijalar shuni koʻrsatdiki, yangi chandiqlarda toʻliq klinik remissiya 77% hollarda, eski chandiqlarda esa 50% hollarda kuzatildi. Xulosa qilib aytganda, keloid chandiqlarni ilk bosqichda davolash triamsinolon terapiyasining samaradorligini deyarli 2 barobar oshiradi.

References

1. Bock, O., Schmid-Ott, G., Mrowietz, U., et al. (2006). Quality of life of patients with keloid and hypertrophic scarring. Arch. Dermatol. Res, 297, 433–438.

2. Ogawa, R. (2017). Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int. J. Mol. Sci, 18(3).

3. Durani, P., McGrouther, D. A., & Ferguson, M. W. (2009). Current scales for assessing human scarring: a review. J. Plast. Reconstr. Aesthet. Surg, 62, 713–720.

4. Gold, M. H., McGuire, M., Mustoe, T. A., et al. (2014). Updated international clinical recommendations on scar management. Dermatol. Surg, 40, 825–831.

5. Leventhal, D., Furr, M., & Reiter, D. (2006). Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch. Facial Plast. Surg, 8, 362–368.

6. Alster, T. S., & Tanzi, E. L. (2003). Hypertrophic scars and keloids: etiology and management. Am. J. Clin. Dermatol, 4(4), 235–243.

7. Gauglitz, G. G., Korting, H. C., Pavicic, T., et al. (2011). Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol. Med, 17, 113–125.

8. Atiyeh, B. S. (2007). Nonsurgical management of hypertrophic scars: evidence-based therapies, standard practices, and emerging methods. Aesthetic Plast. Surg, 31, 468–492.

9. Darzi, M. A., Chowdri, N. A., Kaul, S. K., & Khan, M. (1992). Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br. J. Plast. Surg, 45, 374–379.

10. Zhang, G. Y., Yi, C. G., Li, X., et al. (2009). Triamcinolone inhibits the proliferation and invasion of human keloid fibroblasts by down-regulation of VEGF expression. Aesthetic Plast. Surg, 33, 340–346.

11. Mustoe, T. A., Cooter, R. D., Gold, M. H., et al. (2002). International clinical recommendations on scar management. Plast. Reconstr. Surg, 110, 560–571.

12. Bijlard, E., Kouwenberg, C. A., Timman, R., et al. (2017). Burden of keloid disease: a cross-sectional health-related quality of life assessment. Acta Derm. Venereol, 97, 225–229.

13. Ketchum, L. D., Cohen, I. K., & Masters, F. W. (1974). Hypertrophic scars and keloids: a collective review. Plast. Reconstr. Surg, 53, 140–154.

14. Har-Shai, Y., Amar, M., & Sabo, E. (2003). Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast. Reconstr. Surg, 111, 1841–1852.

15. Rusciani, L., Paradisi, A., Alfano, C., et al. (2006). Cryotherapy in the treatment of keloids. J. Drugs Dermatol, 5, 591–595.

16. Layton, A. M., Yip, J., & Cunliffe, W. J. (1994). A comparison of intralesional triamcinolone and cryosurgery in the treatment of acne keloids. Br. J. Dermatol, 130, 498–501.

17. Shaffer, J. J., Taylor, S. C., & Cook-Bolden, F. (2002). Keloidal scars: a review with a critical look at therapeutic options. J. Am. Acad. Dermatol, 46(2).

Downloads

Published

2026-09-17

How to Cite

1.
Boymuradov SA, G‘aybullayev JG. TRIAMSINOLON PREPARATI YORDAMIDA YUZ VA BOʻYIN SOHASIDA JOYLASHGAN YANGI VA ESKI KELOID CHANDIQLARNI DAVOLASH SAMARADORLIGINI TAQQOSLASH. TTI [Internet]. 2026 Sep. 17 [cited 2026 Nov. 18];2(9):8-12. Available from: https://tibbiyot-talimi-va-innovatsiyalari.uz/index.php/TTI/article/view/73
Vol. 2 No. 9 (2026): Journal of "Medical Education and Innovations"